Please search first.
- If you find the ptoduct you want to submit and list, update thd details.
- If you could nto find the appropriate or want to introduce your own information, make new one.
Code Name:
Product Details
Updated on | EX) Edc 15, 2010 | |
---|---|---|
Updated by | EX) Michael m@abcpharm. | |
Originator | EX)ABC Pharm. Ltd. bd@abcpharm.com | |
Nationality of originator | EX) USA | |
Web site | EX) www.abcd.com/research/pipeline.htm | |
Partners for co-development, licensing, distribution | EX) A Company | |
Lab. code or Brand name | EX) AB001 | |
API, raw material | EX) ab(IVV), ac(USAN), ad(BAN) | |
Product Type | EX) New samll molecule | |
Action Mechanism | EX) Histone deacetylase(HEAC) inhibitor | |
Feature | EX) orphan in USA, Europe Fast acting, long duration. pH depend controlled-release formulation. the first FD tearment. a peptide by using A Pharma's SP ®-technology |
|
Pharmaceutial Form | EX) Oral tablet, sustained release | |
Unit dosage | EX) mg/tablet or mg/ml | |
Posology | EX) Once a day or two times a day | |
WHO ATC | EX) A00B (first 3 level of ATC Classification System) | |
Indication | EX) Asthma | |
Lates development stage | EX) Phase Ⅲ | |
Generic (bio-similar) developers | EX) A Company |